Tanguy Lim Seiwert

Assistant Professor


Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Tanguy Lim Seiwert is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer

Brisson, R. J., Kochanny, S., Arshad, S., Dekker, A., DeSouza, J. A., Saloura, V., Vokes, E. E. & Seiwert, T. Y., Jan 1 2019, (Accepted/In press) In : Head and Neck.

Research output: Contribution to journalArticle

  • Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)

    Pai, S. I., Faivre, S., Licitra, L., Machiels, J. P., Vermorken, J. B., Bruzzi, P., Gruenwald, V., Giglio, R. E., Leemans, C. R., Lim Seiwert, T. & Soulieres, D., Apr 3 2019, In : Journal for immunotherapy of cancer. 7, 1, 96.

    Research output: Contribution to journalReview article

    Open Access
  • Development and validation of a combined hypoxia and immune prognostic classifier for head and neck cancer

    Brooks, J. M., Menezes, A. N., Ibrahim, M., Archer, L., Lal, N., Bagnall, C. J., Von Zeidler, S. V., Valentine, H. R., Spruce, R. J., Batis, N., Bryant, J. L., Hartley, M., Kaul, B., Ryan, G. B., Bao, R., Khattri, A., Lee, S. P., Ogbureke, K. U. E., Middleton, G., Tennant, D. A. & 7 others, Beggs, A. D., Deeks, J., West, C. M. L., Cazier, J. B., Willcox, B. E., Seiwert, T. Y. & Mehanna, H., Sep 1 2019, In : Clinical Cancer Research. 25, 17, p. 5315-5328 14 p.

    Research output: Contribution to journalArticle

    Open Access
  • Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: Implications for immunotherapy

    Chen, Y. P., Wang, Y. Q., Lv, J. W., Li, Y. Q., Chua, M. L. K., Le, Q. T., Lee, N., Dimitrios Colevas, A., Lim Seiwert, T., Hayes, D. N., Riaz, N., Vermorken, J. B., O'Sullivan, B., He, Q. M., Yang, X. J., Tang, L. L., Mao, Y. P., Sun, Y., Liu, N. & Ma, J., Jan 1 2019, In : Annals of Oncology. 30, 1, p. 68-75 8 p.

    Research output: Contribution to journalArticle

  • Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma

    Ren, L., Leisegang, M., Deng, B., Matsuda, T., Kiyotani, K., Kato, T., Harada, M., Park, J. H., Saloura, V., Lim Seiwert, T., Vokes, E., Agrawal, N. & Nakamura, Y., Apr 3 2019, In : OncoImmunology. 8, 4, e1568813.

    Research output: Contribution to journalArticle

    Open Access